|
Powered by Cell Signaling Technology |
Site Information |
---|
AMBIGUOUS SITES: MYH1 (human): , MYH10 (human): , MYH11 (human): , MYH13 (human): , MYH14 (human): , MYH15 (human): , MYH2 (human): , MYH3 (human): , MYH4 (human): , MYH6 (human): , MYH7 (human): , MYH7B (human): , MYH8 (human): , MYH9 (human): , MYO16 (human): , MYO1A (human): , MYO1B (human): , MYO1C (human): , MYO1D (human): , MYO1G (human): , MYO3A (human): , MYO3B (human): , MYO5A (human): , MYO5B (human): , MYO5C (human): , MYO6 (human): , MYO7A (human): , MYO9A (human): , MYO9B (human): |
TSQYLLEkSRIVFQA SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 964528982 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Relevant cell line - cell type - tissue: |
References | |
---|---|
Akimov V, et al. (2018) UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol 25, 631-640
29967540 Curated Info |